Notice of a Webinar to Discuss Changes to PAR-13-343 "Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) (U01)"

Notice Number: NOT-NS-13-041

Key Dates
Release Date: September 23, 2013

Related Announcements

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)


This webinar is intended to inform the academic community about the changes to be found in the revised Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) U01 funding opportunity announcement (PAR-13-343), reissued on August 30, 2013. Time will be allotted for questions and answers.

The NeuroNEXT is designed to increase the efficiency of clinical trials, to facilitate patient recruitment and retention, to increase the quality of neuroscience clinical trials, and to enable public-private partnerships. The network includes multiple Clinical Sites, one Clinical Coordinating Center (CCC), and one Data Coordinating Center (DCC); a listing of the sites may be found on the NeuroNEXT website ( This clinical research network provides a robust, standardized, and accessible infrastructure to facilitate rapid development and implementation of protocols in neurological disorders affecting adult and/or pediatric populations.

Webinar Information
November 22, 2013 (12:00PM - 1:00PM EST)

Instructions for joining the webinar:
1. Go to this link to join the webinar:
2. You will be connected to audio using your computer's microphone and speakers (VoIP). A headset is recommended.
Or, you may select "Use Telephone" after joining the webinar, using the following information:
Teleconference number: 1-702-489-0003
Access code: 999-883-025
Audio PIN: Shown after joining the Webinar


Please direct all inquiries to:

Amanda Sibley, DPhil, MPH
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: (301) 496-9135